🇺🇸 FDA
Pipeline program

Sertraline Hydrochloride

SCI-CT-0001

Approved small_molecule completed

Quick answer

Sertraline Hydrochloride for COVID-19 Vaccine Adverse Reaction is a Approved program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
COVID-19 Vaccine Adverse Reaction
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials